FSSAI launches dedicated licensing window for Ayurveda Aahara products

New Delhi:  The Food Safety and Standards Authority of India (FSSAI), under the Ministry of Health and Family Welfare, has officially launched a dedicated licensing and registration window for Ayurveda Aahara products on its Food Safety Compliance System (FoSCoS) portal. This significant step will enable manufacturers across India to seamlessly apply for licenses to produce and market traditional Ayurvedic foods.

The new ‘Kind of Business’ (KoB) framework for Ayurveda Aahara aims to formalise and streamline the sector, aligning traditional recipes—as documented in authoritative Ayurveda texts—with contemporary food safety and quality standards. This move is designed to boost the food and Ayurveda industries by creating a regulated pathway for these products to reach the market.

This regulation is rooted in the core Ayurvedic principle of personalized nutrition, which tailors diet to an individual’s specific constitution (prakriti). By standardizing these traditional formulations, the FSSAI measure is expected to support the growth of the food and Ayurveda industries. Furthermore, the availability of authentic and regulated Ayurveda Aahara will serve as a critical support for prescribed Ayurvedic treatment plans.

To facilitate a smooth transition for the industry, FSSAI has already published a list of 91 approved Ayurveda Aahara recipes via an order dated 25th July 2025. This provides Food Business Operators with a clear, pre-approved reference for manufacturing products under this new category, ensuring both authenticity and regulatory compliance.

This initiative, developed in close collaboration with the Ministry of Ayush, reflects the Government of India’s commitment to integrating the profound wisdom of Ayurveda with modern food safety practices, thereby benefiting both industry stakeholders and public health.

Related Posts

DCGI Cracks Down On 90 Unapproved Fixed-Dose Combinations: Cough Syrups, Vitamins, Diabetes Drugs Among Those Flagged For Sale Without Central Approval

New Delhi — India’s top drug regulator has issued a nationwide alert over 90 fixed-dose combination (FDC) drugs being manufactured and sold without mandatory central approval, directing all state and…

India’s drug body flags 90 unapproved FDC medicines, states told to take action

The Central Drugs Standard Control Organisation (CDSCO), India’s top drug regulator, has identified at least 90 unapproved fixed-dose combination (FDC) medicines in circulation and asked states to move against those…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

DCGI Cracks Down On 90 Unapproved Fixed-Dose Combinations: Cough Syrups, Vitamins, Diabetes Drugs Among Those Flagged For Sale Without Central Approval

DCGI Cracks Down On 90 Unapproved Fixed-Dose Combinations: Cough Syrups, Vitamins, Diabetes Drugs Among Those Flagged For Sale Without Central Approval

India’s drug body flags 90 unapproved FDC medicines, states told to take action

India’s drug body flags 90 unapproved FDC medicines, states told to take action

India advancing as a global hub of affordable, quality healthcare solutions: Dr Jitendra Singh

India advancing as a global hub of affordable, quality healthcare solutions: Dr Jitendra Singh

Unapproved drops for dry eyes pose risks: Govt

Unapproved drops for dry eyes pose risks: Govt

Semaglutide Patent Expires: Will Diabetes, Weight-Loss Treatment Become More Accessible For Patients?

Semaglutide Patent Expires: Will Diabetes, Weight-Loss Treatment Become More Accessible For Patients?

Inaugural Conference of ‘Critical Nephrology Society of India’ (CNSI) puts Best Foot Forward

Inaugural Conference of ‘Critical Nephrology Society of India’ (CNSI) puts Best Foot Forward